×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| BAFNA PHARMACEUTICALS LTD. | 333.77 | 9.48 | 331.88 | 0.40 | 175.0 | 37.4 |
| LACTOSE (INDIA) LTD. | 292.80 | 2.18 | 287.19 | 0.17 | 172 | 24.9 |
| DENIS CHEM LAB LTD | 431.41 | 17.61 | 428.41 | 1.27 | 169 | 16.8 |
Bafna Pharmaceuticals Limited, with Security Code 532989, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.9 | 34.2 | 42.2 | 41.9 | 40.6 | 28.4 | 41.3 | 33.2 | 40.3 | 33.1 |
| Expenses | 19.4 | 30.7 | 34.6 | 35.7 | 36.7 | 30.5 | 38.5 | 32.1 | 36.5 | 30.1 |
| Operating Profit | 2.5 | 3.6 | 7.6 | 6.3 | 4.0 | -2.1 | 2.9 | 1.2 | 3.8 | 3.1 |
| OPM % | 11.57% | 10.38% | 18.04% | 15.01% | 9.84% | -7.3% | 6.97% | 3.64% | 9.41% | 9.22% |
| Other Income | 0.6 | 1.4 | 0.3 | 1.9 | 0.2 | 1.0 | 0.5 | 0.2 | 1.0 | 0.2 |
| Interest | 0.5 | 0.6 | 0.7 | 0.6 | 0.4 | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 |
| Depreciation | 1.1 | 1.4 | 1.5 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.7 |
| Profit before tax | 1.6 | 3.0 | 5.7 | 6.4 | 2.5 | -2.9 | 1.5 | -0.4 | 2.6 | 1.0 |
| Tax % | 0% | 0% | 4.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 1.6 | 3.0 | 5.4 | 6.4 | 2.5 | -2.9 | 1.5 | -0.7 | 2.6 | 0.9 |
| EPS in Rs | 0.68 | 1.26 | 2.34 | 2.68 | 1.05 | -1.24 | 0.62 | -0.31 | 1.11 | 0.4 |
| Metrics | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 |
|---|---|---|---|---|
| Sales | 6.8 | 11.6 | 10.9 | 13.1 |
| Expenses | 9.7 | 11.9 | 10.5 | 9.2 |
| Operating Profit | -2.9 | -0.4 | 0.4 | 4.0 |
| OPM % | -41.9% | -3.2% | 3.9% | 30.1% |
| Other Income | 0.3 | 0.6 | -21.7 | -1.5 |
| Interest | 0.1 | 0.0 | 0.1 | 0.0 |
| Depreciation | 1.0 | 0.7 | 1.0 | 0.5 |
| Profit before tax | -3.7 | -0.6 | -0.6 | 2.7 |
| Tax % | -42.6% | -7.3% | -0.2% | 72.3% |
| Net Profit | -2.1 | -0.6 | -22.3 | 0.3 |
| EPS in Rs | 0 | 0 | -94 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 28% |
| 3 Years: | 29% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 19% |
| 3 Years: | 8% |
| TTM: | -59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 0% |
| 3 Years: | -18% |
| 1 Year: | -18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -15% |
| 3 Years: | -13% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 24% |
| TTM: | 90% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 0% |
| 3 Years: | -18% |
| 1 Year: | -18% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|